The Coronary Artery Disease Therapeutics Market was valued at US$ 19.7 Billion in 2025 and is projected to reach US$ 27.77 Billion by 2034, registering a CAGR of 4.39% during 2026–2034. The market is expanding as healthcare providers and pharmaceutical companies respond to the persistent global burden of coronary artery disease, increasing cardiovascular risk factors,...